Serum levels of six tumor markers in patients with benign and malignant gynecological disease I. FukazawaN. InabaB. Wiklund Originals Pages: 61 - 68
Experiments with tissue cultures from a human ovarian serous cystadenocarcinoma producing cancer antigen 125 (CA125), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) I. FukazawaN. InabaH. Tokita Originals Pages: 69 - 81
Relationship between serum prolactin concentration, vascular angiotensin sensitivity and arterial blood pressure during third trimester pregnancy T. ÖneyO. BellmannH. Kaulhausen Originals Pages: 83 - 90
Serum CA-125 as a guideline for the timing of a second-look operation and second-line treatment in ovarian cancer W. JägerR. AdamN. Lang Originals Pages: 91 - 99
Factors influencing the success of microsurgery for distal tubal occlusion T. J. LaatikainenA. K. TenhunenD. L. Apter Originals Pages: 101 - 106
Quantitative analysis of a novel pregnancy-associated protein in trophoblastic diseases, normal pregnancy and healthy female subjects M. NakaiM. AtsumiM. Arai Originals Pages: 107 - 110
Experience with the treatment of metastatic ovarian carcinoma K. ShiromizuT. KawanaM. Mizuno Originals Pages: 111 - 114
A sex cord stromal tumour in a woman with XO/XX/XXX-mosaicism D. GlaserH. NienhausI. H. Pawlowitzki Case Reports Pages: 115 - 118